Viewing StudyNCT00498225



Ignite Creation Date: 2024-05-05 @ 6:31 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00498225
Status: COMPLETED
Last Update Posted: 2012-11-02
First Post: 2007-07-06

Brief Title: Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer
Sponsor: Taiho Pharmaceutical Co Ltd
Organization: Taiho Pharmaceutical Co Ltd

Organization Data

Organization: Taiho Pharmaceutical Co Ltd
Class: INDUSTRY
Study ID: 01023017
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Taiho Pharmaceutical Co Ltd
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
TTY Biopharm INDUSTRY